GlycoFi, Inc. Signs Research Collaboration With Centocor, Inc. (JNJ) To Evaluate The Expression Of Two Proteins 
10/19/2005 5:13:16 PM

LEBANON, N.H.--(BUSINESS WIRE)--April 13, 2005--GlycoFi announced today that they initiated a collaboration with Centocor, Inc, to determine the feasibility of producing a Centocor protein using GlycoFi's proprietary yeast-based glycoprotein production technology. Under the agreement, Centocor has the option to use the GlycoFi-yeast based production system for future protein expression in return for milestone payments and royalties to GlycoFi. Financial details were not disclosed. In an on-going research study funded by Centocor, GlycoFi and Centocor are also evaluating the use of GlycoFi technology for the production of an undisclosed Centocor antibody. These two collaborations combine GlycoFi's unique expression technology for the production of human glycoproteins, including antibodies, with Centocor's expertise in the area of therapeutic proteins.